Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Microfluidics Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The microfluidics market has experienced considerable expansion recently. Its valuation is anticipated to rise from $10.33 billion in 2025 to $11.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. This historical growth is largely due to factors such as increased research in laboratory-on-a-chip technology, a heightened need for miniaturized diagnostic devices, their integration into pharmaceutical R&D, the broadening scope of analytical and clinical testing, and progress in creating silicon and glass-based microfluidic devices.
The microfluidics market is projected to experience significant expansion over the coming years. This market is forecast to reach $20.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. Factors contributing to this growth during the projected period include the increasing uptake in point-of-care diagnostics, the expansion of personalized medicine applications, the broadening of polymer-based microfluidics, enhanced integration with IoT and smart lab systems, and progress in high-throughput screening technologies. Key trends anticipated for the forecast timeframe encompass the incorporation of microfluidics into drug delivery systems, its utilization in clinical diagnostics, the widening scope of pharmaceutical and life science research applications, the creation of industrial and environmental microfluidics solutions, and improvements in high-precision fluid manipulation technologies.
Get A Free Sample Report With In-Depth Market Insights:
Microfluidics Market Growth Backed By Core Demand Fundamentals
The historical growth of the microfluidics market was aided by an increase in clinical studies for cell-based therapies. Microfluidics has emerged as a promising platform to advance biomanufacturing in drug, gene, and cell therapies, achieving this through enhanced synthesis of nanoscale drug/gene delivery systems, effective microencapsulation of drugs or cells, precise intracellular delivery of macromolecules, and the creation of macroscale constructs from micro-nano-fibers. For instance, in July 2023, the American Society of Gene and Cell Therapy, a US-based medical and scientific development organization, reported that the number of non-oncology gene and cell therapy clinical trials rose by 58% in the second quarter of 2023 compared to the first quarter of 2023. Consequently, the rising volume of clinical studies for cell-based therapies is expected to drive the microfluidics market’s growth throughout the forecast period.
Microfluidics Market Segment Analysis Spotlighting Growth Areas
The microfluidics market covered in this report is segmented –
1) By Material: Silicon-Based Microfluidics, Glass-Based Microfluidics, Polymer-Based Microfluidics
2) By Technology: Droplet-Based Microfluidics, Continuous-Flow Microfluidics, Digital Microfluidics, Paper-Based Microfluidics, Centrifugal Microfluidics, Organ-on-a-Chip Platforms
3) By Application: Industrial And Environmental, Drug Delivery, Pharmaceutical And Life Science Research, Analysis, Clinical And Veterinary Diagnostics
Subsegments:
1) By Silicon-Based Microfluidics: Bulk Micromachined Silicon, Silicon-on-Insulator (SOI), Nano-Structured Silicon
2) By Glass-Based Microfluidics: Borosilicate Glass, Fused Silica Glass, Soda-Lime Glass
3) By Polymer-Based Microfluidics: Polydimethylsiloxane (PDMS), Poly(methyl methacrylate) (PMMA), Polycarbonate (PC)
Microfluidics Market Growth Trends Reshaping The Competitive Landscape
Leading firms within the microfluidics market are concentrating on creating sophisticated solutions, including lab-on-a-chip devices and integrated microfluidic platforms, aimed at boosting diagnostic accuracy, decreasing sample processing durations, and improving point-of-care testing. Such lab-on-a-chip devices are defined as compact systems that combine several laboratory processes onto a singular chip, allowing for quicker and more precise analyses using only small sample quantities. An illustrative example is Takara Bio, a scientific reagents manufacturer based in Japan, which introduced its initial commercial dissolvable microfluidic lentiviral transduction enhancer in March 2024. This product employs a distinctive dissolvable microfluidic platform to achieve exact control of the transduction process, thereby improving the delivery of lentiviral vectors into specific cells. The enhancer’s purpose is to substantially boost the efficacy of lentiviral transduction, which is vital for gene therapy, ensuring more potent gene transfer into cells, while also streamlining experimental procedures, allowing researchers to utilize it with ease, without the need for vast technical knowledge.
Microfluidics Market Industry Leaders And Competitive Landscape
Major companies operating in the microfluidics market report are Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Dolomite Microfluidics, PerkinElmer, Inc., Sphere Fluidics Limited, Micronit Micro Technologies B.V., Fluigent, Elveflow, Cellix Ltd., Microliquid S.L., Biosurfit S.A., FlowJEM, uFluidix, QuantWave Technologies Inc., Harvard Bioscience, Inc., Abaxis, Inc., OPKO Health, Inc., Abbott, Stämm
View The Full Microfluidics Market Report:
Microfluidics Market Regional Analysis And Top Geography
North America was the largest region in the microfluidics market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the microfluidics market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.